A 65-year-old man presented with remittent fever and macrocytic anemia. His hemoglobin level was 7.6 g/dL, mean corpuscular volume 105 fL, white blood cell count 2,200/µL, and platelet count 272 × 10
3/µL. Bone marrow aspirates showed 40% cellularity with marked erythroid hypoplasia and dysplasia of granulocyte- and megakaryocyte-lineage cells. Blasts, comprising 17.8% of nucleated cells, were composed of two populations: type A blasts were myeloperoxidase-positive myeloid precursors, while type B blasts had an eccentric nucleus and abundant cytoplasm, and electron microscopic examination revealed tubuloreticular inclusions. Flow cytometry discriminated a mononuclear cell population that expressed CD4, CD36, CD45RA, CD123, CD303, CD304, and HLA-DR, but lacked CD1a, CD11c, CD34, and CD56 and lineage-specific markers; this phenotype most likely represented type B blasts. G-banding revealed del(5)(q13q33) as the sole cytogenetic abnormality and 79.7% of interphase nuclei, including those of both types of blasts, were found to lack one 5q31 signal by fluorescence
in situ hybridization. The patient responded well to daunorubicin-cytarabine induction chemotherapy and successfully underwent allogeneic hematopoietic stem cell transplantation, achieving long-term disease-free survival. We herein describe a rare case of myelodysplastic syndrome, in which blasts differentiated to plasmacytoid dendritic cells
in vivo. The biological and clinical significance of this rare condition remains to be clarified.
View full abstract